<DOC>
	<DOCNO>NCT01438892</DOCNO>
	<brief_summary>Several observational study evaluate comparative treatment cost associate agent , particularly within anti-TNF class , evaluate impact therapy compliance , persistence , treatment pattern patient report outcome , healthcare utilization cost , use provider database . This study design fill information gap .</brief_summary>
	<brief_title>Impact Of RA Therapy Compliance On Patient-Reported Outcomes</brief_title>
	<detailed_description>Cohort observational</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adults moderate severe RA currently use DMARD Psoriatic Arthritis ( PsA ) , Psoriasis ( PsO ) , SSystemic Lupus Erythematosus ( SLE ) , NonDisease modify antirheumatic disease ( nonDMARD ) use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>therapy compliance</keyword>
</DOC>